Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United States
美国真实世界临床数据显示，心血管不良事件与免疫检查点抑制剂的使用相关。
期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2021.100252
Jain, P; Gutierrez Bugarin, J; Guha, A; Jain, C; Patil, N; Shen, T; Stanevich, I; Nikore, V; Margolin, K; Ernstoff, M; Velcheti, V; Barnholtz-Sloan, J; Dowlati, A
